Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score

Kumar, Shaji K.; Gertz, Morie A.; Lacy, Martha Q.; Dingli, David; Hayman, Suzanne R.; Buadi, Francis K.; Short-Detweiler, Kristen; Zeldenrust, Steven R.; Leung, Nelson; Greipp, Philip R.; Lust, John A.; Russell, Stephen J.; Kyle, Robert A.; Rajkumar, S. Vincent; Dispenzieri, Angela
January 2011
Mayo Clinic Proceedings;Jan2011, Vol. 86 Issue 1, p12
Academic Journal
OBJECTIVE: To examine whether the outcome of patients with primary systemic amyioidosis (AL) has improved over time and to identify predictors of early mortality in patients with AL. PATIENTS AND METHODS: We studied 2 separate cohorts of patients. The first cohort, consisting of 1998 patients with AL seen at Mayo Clinic between January 1977 and August 2006, was used to examine the trends in overall survival (OS) from diagnosis during this 30-year period. The second cohort, consisting of 313 patients seen between September 2006 and August 2009, was used to validate a model for predicting early mortality. RESULTS: The 4-year OS from diagnosis improved during each decade of follow-up: 21%, 24%, and 33%, respectively, for the periods 1977-1986,1987-1996, and 1997-2006 (P<.001). Within the last group (1997.2006), 4-year OS during 1997-1999,2000-2002, and 2003-2006 was 28%, 30%, and 42%, respectively (P=.02). However, the 1-year mortality remained high during the 30-year period. A risk stratification score using cardiac troponin T, N-terminal pro-brain natriuretic peptide, and uric acid identified patients at risk of early mortality. The 1-year mortality with 0, 1, 2, or 3 risk factors was 19%, 37%, 61%, and 80%, respectively, in this training cohort of 459 patients. This was confirmed in a validation cohort of 313 patients. CONCLUSION: Survival in AL has improved over time, with maximum improvement occurring in the past decade. However, early mortality remains high, and prospective identification of patients at risk of early mortality may allow development of risk-adapted strategies.


Related Articles

  • Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction. Liu, Dan; Hu, Kai; Störk, Stefan; Herrmann, Sebastian; Kramer, Bastian; Cikes, Maja; Gaudron, Philipp Daniel; Knop, Stefan; Ertl, Georg; Bijnens, Bart; Weidemann, Frank // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    Objectives: Since diastolic abnormalities are typical findings of cardiac amyloidosis (CA), we hypothesized that speckle-tracking-imaging (STI) derived longitudinal early diastolic strain rate (LSRdias) could predict outcome in CA patients with preserved left ventricular ejection fraction (LVEF...

  • Malignancy and mortality in people with coeliac disease: population based cohort study. West, Joe; Logan, Richard F. A.; Smith, Chris J.; Hubbard, Richard B.; Card, Timothy R. // BMJ: British Medical Journal (International Edition);9/25/2004, Vol. 329 Issue 7468, p716 

    Objective To quantify the risks of malignancy and mortality in people with coeliac disease compared with the general population. Design Population based cohort study. Setting General practice research database. Participants 4732 people with coeliac disease and 23 620 matched controls. Main...

  • Mortality from infective endocarditis: clinical predictors of outcome. Wallace, S.M.; Walton, B.I.; Kharbanda, R.K.; Hardy, R.; Wilson, A.P.; Swanton, R.H. // Heart;Jul2002, Vol. 88 Issue 1, p53 

    Objective: To identify clinical markers available within the first 48 hours of admission that are associated with poor outcome in infective endocarditis. Designs: Retrospective cohort study. Setting: Teaching hospital. Patients: 208 of 220 patients with infective endocarditis. Methods:...

  • Tightening up on TAVI to extract stronger evidence. Brosky, John // Medical Device Daily;5/24/2011, Vol. 15 Issue 100, p1 

    The article discusses a tightening up of requirements for the transcatheter aortic valve replacement (TAVI) for entry into the U.S. The first patient registries to validate its performance and patient outcomes were published in Europe leading to a clinical consensus that it is a safe procedure....

  • Russian mortality trends for 1991-2001: analysis by cause and region. Men, Tamara; Zaridze, David; Brennan, Paul; Boffetta, Paolo // BMJ: British Medical Journal (International Edition);10/25/2003, Vol. 327 Issue 7421, p964 

    Abstract Objectives: To investigate trends in Russian mortality for 1991-2001 with particular reference to trends since the Russian economic crisis in 1998 and to geographical differences within Russia. Design: Analysis of data obtained from the Russian State statistics committee for 1991-2001....

  • Renal involvement in AL amyloidosis: the facts, the promise and the hope*. Ronco, Pierre; Aucouturier, Pierre // Nephrology Dialysis Transplantation;Oct2009, Vol. 24 Issue 10, p2967 

    The authors comments on a study discussed within the issue which explored the long-term outcomes of 145 patients with biopsy-proven AL amyloidosis. The authors tackled the issue of the pathophysiology of amyloid deposition. They contend that the study yielded three important information. These...

  • Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Said, Samar M; Sethi, Sanjeev; Valeri, Anthony M; Chang, Anthony; Nast, Cynthia C; Krahl, Leslie; Molloy, Peter; Barry, Marc; Fidler, Mary E; Cornell, Lynn D; Leung, Nelson; Vrana, Julie A; Theis, Jason D; Dogan, Ahmet; Nasr, Samih H // Kidney International;Aug2014, Vol. 86 Issue 2, p370 

    Amyloidosis derived from leukocyte chemotactic factor 2 (ALECT2) is a recently described disease. Here, we report the characteristics and outcome of 72 patients with renal ALECT2, which included 19 who had another kidney disease on biopsy. Ninety-two percent of patients were Hispanics and over...

  • End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. Tang, Wen; McDonald, Stephen P.; Hawley, Carmel M.; Badve, Sunil V.; Boudville, Neil; Brown, Fiona G.; Clayton, Philip A.; Campbell, Scott B.; de Zoysa, Janak R.; Johnson, David W. // Nephrology Dialysis Transplantation;Feb2013, Vol. 28 Issue 2, p455 

    Background There are few reports regarding the long-term renal replacement therapy (RRT) outcomes of amyloidosis. Methods In this retrospective, multi-centre, multi-country registry analysis, all patients with and without amyloidosis who commenced RRT for end-stage renal failure (ESRF) in...

  • Telemonitoring study offers no reduction in readmissions. McCarty, Mark // Medical Device Daily;5/30/2012, Vol. 16 Issue 102, p1 

    The article reports on the findings of a study by the Mayo Clinic on the benefits of telemonitoring. Study results suggest that there is no difference in readmissions among patients with several diseases. Over 200 patients were randomized to standard care and the use of telemonitoring like daily...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics